Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$150,000.00
Sep 1, 2022
For-profit organization
Conveyor Sorting Robot with Integrated AI Vision System for Food Manufacturing
997829
Singulation, sortation, and visual inspection of food products before they are fed into packaging machines is one of the most labor intensive processes in food manufacturing. Laplace Robotics is building a core technology needed to singulate, sort and reject food products on a live conveyor using AI vision technology.
$120,000.00
Sep 1, 2022
For-profit organization
Business-to-business e-commerce extensions for fresh food service distribution software platform
997900
Software development project to expand the firm's fresh food distribution software platform
$135,000.00
Sep 1, 2022
For-profit organization
New IntelliFlux system for defect characterization and predictive process control in the manufacture of tailor welded blanks
998035
This project will accelerate the commercialization of Impact AI’s IntelliFlux software by supporting the necessary software engineering and integration testing for commercial deployment.
This project will further develop a machine learning framework that predicts when defects are likely to occur within the End User’s manufacturing process.
$10,000.00
Sep 1, 2022
For-profit organization
SheBoot Project to Assist with Business Startup
998066
Imaginable Solutions will develop its manufacturing capacity and begin to create an investment and IP strategy.
$10,000,000.00
Sep 1, 2022
For-profit organization
Providence COVID-19 Vaccine Development - STAGE 3
998413
Providence Therapeutics intends to continue the clinical development of a made-in-Canada mRNA vaccine against COVID-19. The firm is expecting to initiate a Phase 3 clinical trial on PTX-COVID19-B in mid-2023 and pursue market or emergency approvals to commercialize in late 2023 or early 2024. The objective of this project is to facilitate the company's R&D efforts and vaccine development program to begin a Phase 3 clinical trial in 2023.
$102,000.00
Sep 1, 2022
For-profit organization
Elarex Viral Vectored Exosomal Vaccine Development and Stabilization
998641
Optimization of ultra-stable formulation for viral vectored vaccine, compatible with oral dosing
$500,000.00
Sep 1, 2022
For-profit organization
Vertical expansion and sustainability
999391
Automator Group Inc. is preparing to expand into new adjacent verticals.
$135,000.00
Sep 1, 2022
For-profit organization
Improving Protein Content in Pulse and Oilseed Crops
999784
AgGene is targeting the improvement of protein content in economically important pulse and oilseed crops through the use of advanced plant breeding technology. AgGene has characterized a portfolio of genetic targets that can be manipulated through the use of genome editing to drive high protein content in seed tissues. High protein seed commodities can be leveraged for the expanding plant protein sector to help position Canada as a global leader in plant-based protein production.
$10,192.50
Sep 1, 2022
For-profit organization
HTUO Biosciences Inc.-2022-2023-1000353
1000353
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.
$10,000,000.00
Sep 1, 2022
For-profit organization
COVID-19 Vaccine: Phase 3 Clinical Trial of DNA-Based Vaccine Booster Covigenix VAX-001-1c
1000363
Entos has developed Covigenix VAX-001, a DNA Proteo-Lipid Vehicle (PLV) vaccine intended for the prevention of COVID-19 infection by SARS-CoV-2. In this project, Entos will advance the VAX-001-1c bivalent vaccine candidate through Phase 3 clinical trials to establish its safety and immunogenicity in healthy adults as a booster to approved vaccines.